Akter, A., & Alam, M. (2022). Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis. Brac University.
Čikaški stil citiranja (17. izdanje)Akter, Anika, i Marzia Alam. Pharmacokinetics, Safety, Efficacy and Immunogenicity of Adalimumab Biosimilar ABP-501in Rheumatoid Arthritis and Plaque Psoriasis. Brac University, 2022.
MLA način citiranja (8. izdanje)Akter, Anika, i Marzia Alam. Pharmacokinetics, Safety, Efficacy and Immunogenicity of Adalimumab Biosimilar ABP-501in Rheumatoid Arthritis and Plaque Psoriasis. Brac University, 2022.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.